News Releases

2010
2009
2008
2007
2006
2005
2004

Dec 22, 2006 Protox Second Closing Increases Private Placement to $10 Million
Nov 29, 2006 Protox Releases Q3 Financial Results and Company Highlights
Nov 29, 2006 Protox Therapeutics Completes $9.1 Million Private Placement
Nov 21, 2006 Protox Presents PORxin™ Data at International Cancer Conference
Oct 25, 2006 Protox Announces Private Placement
Oct 24, 2006 M. D. Anderson Cancer Center Participates in Protox Prostate Cancer Study
Oct 11, 2006 Protox Receives Approval from Health Canada for BPH Clinical Trial
Sep 21, 2006 Protox Files Clinical Trial Application With Health Canada For BPH
Aug 29, 2006 Protox Releases Q2, 2006 Financial Results and Company Highlights
Aug 24, 2006 Protox Announces New Director of Investor Relations
and Corporate Communications
Aug 10, 2006 Protox Advances Phase I Prostate Cancer Study and Planned BPH Clinical Trial
Aug 1, 2006 Protox Announces New Institutional Investor
July 20, 2006 Protox Acquires Phase II Cancer Program from Neurocrine
and U.S. Public Health Service
June 23, 2006 Protox Therapeutics Retains Leading Investor Relations Firm
June 19, 2006 Protox Announces Changes to Board of Directors
June 15, 2006 Protox Therapeutics to Present at London Biotech Investment Forum
June 14, 2006 Protox Strengthens Intellectual Property Portfolio with New Patent Application
June 7, 2006 Protox Therapeutics to Present at Technology and Life Sciences Forum
May 29, 2006 Protox Releases Q1, 2006 Financial Statements; Prostate Cancer Trial on Track
May 2, 2006 Protox Successfully Doses First Patient in Prostate Cancer Trial using PRX302
May 1, 2006 Protox Therapeutics to Present at BioFinance 2006 Conference
Apr 28, 2006 Protox Releases Financial Statements and Reviews Achievements for 2005
Apr 7, 2006 Protox Therapeutics Grants Stock Options
Apr 3, 2006 Protox Therapeutics Announces Presentation of Data at Leading Cancer Research Conference
Mar 27, 2006 Protox Therapeutics to be featured on CEO Clips on The Biography Channel
Mar 16, 2006 Protox Therapeutics to present at Invest Northwest Conference
Mar 8, 2006 Protox Therapeutics conference call notification
Jan 16, 2006 Protox receives FDA clearance to beginPhase I prostate cancer trial

What's New

June 2 2010
Protox Announces Positive Six Month Phase 2B BPH Results

June 1, 2010
Protox to Present Phase 2B BPH Data at the Annual Meeting of the American Urological Association

May 13, 2010
Protox Reports First Quarter 2010 Financial Results

April 29, 2010
Protox Signs $75 Million License Agreement with Kissei for Commercialization of PRX302 in Japan for BPH and Prostate Disease

 

Events

January 11, 2010 - 8:45 am ET
Protox Therapeutics Conference Call - Webcast Link

 

Stock Quote

LAST TRADE:$0.39
TRADE TIME:3:53PM EST
CHANGE:$0.00 (0.00%)
PREV CLOSE: $0.39
OPEN:$0.39
BID:$0.385
ASK:$0.39